nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgments
|
|
|
2004 |
43 |
S1 |
p. 266-267 2 p. |
artikel |
2 |
Acronyms and abbreviations
|
|
|
2004 |
43 |
S1 |
p. 9-10 2 p. |
artikel |
3 |
Appendix 1: methods used for guideline development
|
|
|
2004 |
43 |
S1 |
p. 231-261 31 p. |
artikel |
4 |
Contents
|
|
|
2004 |
43 |
S1 |
p. A3-A4 nvt p. |
artikel |
5 |
Editorial board
|
|
|
2004 |
43 |
S1 |
p. A2- 1 p. |
artikel |
6 |
Executive summary
|
|
|
2004 |
43 |
S1 |
p. 16-33 18 p. |
artikel |
7 |
Figures
|
|
|
2004 |
43 |
S1 |
p. 6-8 3 p. |
artikel |
8 |
Foreword
|
Eknoyan, Garabed |
|
2004 |
43 |
S1 |
p. 14-15 2 p. |
artikel |
9 |
Guideline 1: goals of antihypertensive therapy in CKD
|
|
|
2004 |
43 |
S1 |
p. 65-230 166 p. |
artikel |
10 |
Guidelines
|
|
|
2004 |
43 |
S1 |
p. 33-64 32 p. |
artikel |
11 |
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
|
|
|
2004 |
43 |
S1 |
p. 11-13 3 p. |
artikel |
12 |
Masthead
|
|
|
2004 |
43 |
S1 |
p. A1- 1 p. |
artikel |
13 |
References
|
|
|
2004 |
43 |
S1 |
p. 268-290 23 p. |
artikel |
14 |
Tables
|
|
|
2004 |
43 |
S1 |
p. 1-5 5 p. |
artikel |
15 |
Work group biographies
|
|
|
2004 |
43 |
S1 |
p. 262-265 4 p. |
artikel |